MARKET

LLY

LLY

Lilly Eli & Co
NYSE
1,056.88
+15.09
+1.45%
After Hours: 1059.50 +2.62 +0.25% 18:18 12/18 EST
OPEN
1,041.80
PREV CLOSE
1,041.79
HIGH
1,079.26
LOW
1,039.54
VOLUME
3.85M
TURNOVER
--
52 WEEK HIGH
1,111.99
52 WEEK LOW
621.50
MARKET CAP
999.16B
P/E (TTM)
51.68
1D
5D
1M
3M
1Y
5Y
1D
Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.
The Motley Fool · 5h ago
Wall Street Lunch: Trump Media Goes Nuclear
Seeking Alpha · 5h ago
Market Voices: Lilly's new obesity pill, NYSE owner eyes crypto firm
Seeking Alpha · 5h ago
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
TipRanks · 6h ago
Medicare-negotiated drug prices to halve out-of-pocket costs next year: report
Seeking Alpha · 6h ago
Better Buy in 2026: Pfizer or Eli Lilly?
The Motley Fool · 7h ago
Merck Cholesterol, Cancer Drugs May Enter FDA Fast-Track Program: Report
Benzinga · 7h ago
Lose Weight on Zepbound, Keep It Off With Eli Lilly's New Pill? Data Say That Works.
Barron‘s · 7h ago
More
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, markets, and sells pharmaceutical products worldwide. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company is also engaged in radiopharmaceutical discovery, development, and manufacturing efforts, and clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). It is evaluating its novel gene therapy candidate, ixoberogene soroparvovec.

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.